Wegovy maker warns of slower profits as rivals bite
The Danish weight loss drug-maker claims "knock-off" treatments are hitting growth.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
